Rodríguez-Espinosa Sara, Coloma-Carmona Ainhoa, Pérez-Carbonell Ana, Román-Quiles José Francisco, Carballo José Luis
Center for Applied Psychology, Department of Health Psychology, Miguel Hernández University, Avenida Universidad, Elche, Spain.
University General Hospital of Elche, Camino de la Almazara, Elche, Spain.
J Stud Alcohol Drugs. 2025 Jan;86(1):58-67. doi: 10.15288/jsad.24-00106. Epub 2024 Jul 23.
Withdrawal syndrome stands out as the strongest risk factor for prescription opioid-use disorder (POUD) and is related to psychological and pain impairment in the chronic pain population. This study aimed to identify profiles of chronic pain patients with opioid withdrawal based on psychological factors and to explore the association between the classes and demographic, clinical, and substance use variables.
This cross-sectional descriptive study involved 391 patients, 221 with interdose withdrawal (mean age = 57.91±13.61 years; 68.3% female). Latent class analysis and bivariate and logistic regression analyses were performed.
Two latent classes were identified (Bayesian information criterion = 4020.72, entropy = .70, likelihood ratio tests < .01): Withdrawal syndrome with No Psychological Distress (WNPD; 45.2%, = 100) and Withdrawal syndrome with Psychological Distress (WPD; 54.8%, = 121). The WPD class was more likely to experience craving, anxiety, and depression and to report higher levels of pain intensity and interference ( < .01). Patients in this class were younger, visited a higher number of specialists, and showed higher rates of high-dose opioid use, misuse, moderate-severe POUD, and tobacco and anxiolytics use ( < .05). Only moderate-severe POUD (odds ratio [OR] = 2.64) and tobacco use (OR = 2.28) increased the risk of WPD class membership.
Although it is common for chronic pain patients to experience withdrawal symptoms during opioid treatment, more than half of the participants reported concomitant psychological distress. Establishing differential profiles can help to improve withdrawal syndrome management during the treatment of chronic pain with opioids.
戒断综合征是处方阿片类药物使用障碍(POUD)最显著的危险因素,且与慢性疼痛人群的心理和疼痛损伤有关。本研究旨在基于心理因素确定阿片类药物戒断的慢性疼痛患者的特征,并探讨这些类别与人口统计学、临床和物质使用变量之间的关联。
这项横断面描述性研究纳入了391名患者,其中221名存在剂量间期戒断(平均年龄 = 57.91±13.61岁;68.3%为女性)。进行了潜在类别分析以及双变量和逻辑回归分析。
确定了两个潜在类别(贝叶斯信息准则 = 4020.72,熵 = 0.70,似然比检验 < 0.01):无心理困扰的戒断综合征(WNPD;45.2%,n = 100)和有心理困扰的戒断综合征(WPD;54.8%,n = 121)。WPD类别更有可能出现渴望、焦虑和抑郁,并且报告的疼痛强度和干扰水平更高(P < 0.01)。该类别中的患者更年轻,就诊的专科医生数量更多,并且高剂量阿片类药物使用、滥用、中度 - 重度POUD以及烟草和抗焦虑药使用的比例更高(P < 0.05)。只有中度 - 重度POUD(优势比[OR] = 2.64)和烟草使用(OR = 2.28)增加了属于WPD类别的风险。
虽然慢性疼痛患者在阿片类药物治疗期间出现戒断症状很常见,但超过一半的参与者报告伴有心理困扰。确定不同的特征有助于改善阿片类药物治疗慢性疼痛期间的戒断综合征管理。